View

Thomas DeLauer

Tesamorelin reduces visceral fat and improves muscle quality, but gene upregulation and synergy claims lack direct evidence.

Strong evidence supports tesamorelin's fat-reducing and muscle-improving effects, but molecular claims about gene expression and peptide synergy are unsupported.

We checked the science

our breakdown of the video

10 claims, each mapped to its moment in the video

Fat inside your belly sends out harmful signals that make your body bad at using sugar and mess up how your organs work.

Multiple causal studies (randomized trials and reviews) support this claim.

A medicine called tesamorelin tricks the brain into making more of its own growth hormone, instead of giving the hormone directly.

Multiple causal studies (randomized trials and reviews) support this claim.

A drug called tesamorelin makes belly fat shrink by 11% in 6 months, while fake pills barely change anything.

Multiple causal studies (randomized trials and reviews) support this claim.

Fat in the liver blocks the body’s ability to manage blood sugar, making it harder to lose weight anywhere else.

Evidence contradicts this claim.

The fat cells don’t just get smaller—they get healthier, with better oxygen and less swelling.

Evidence points in both directions — no clear conclusion yet.

The drug makes core muscles bigger and stronger while reducing the fat that sneaks into them.

Multiple causal studies (randomized trials and reviews) support this claim.

After a year, the drug helped muscles recover faster after exercise because it boosted a hormone that makes mitochondria work better.

Multiple causal studies (randomized trials and reviews) support this claim.

The drug turns on genes that help mitochondria burn fat and make energy more efficiently.

Evidence contradicts this claim.

A different molecule called MOTS-c helps the body use sugar better by turning on a cellular energy switch called AMPK.

Weak evidence — fewer than 20 studies, so treat this as a starting point, not a fact.

One drug helps move fat out of storage, and another helps burn it—so together they work better than either alone.

Evidence contradicts this claim.

Key Takeaways

Summary

Based on the video transcript only.

  1. 1Problem: Visceral fat is dangerous internal fat around organs that causes inflammation, insulin resistance, and fatty liver, and it’s hard to lose with diet and exercise alone.
  2. 2Core methods: Tesamorelin, MOTS-C
  3. 3How methods work: Tesamorelin tells your body to make more of its own growth hormone, which burns visceral and liver fat, improves fat cell health, increases muscle density, and boosts mitochondrial energy production. MOTS-C works inside mitochondria to activate AMPK, helping cells use fuel better and improve insulin sensitivity.
  4. 4Expected outcomes: Up to 18% reduction in visceral fat, reduced liver fat, healthier fat tissue, increased muscle density in the core, improved energy metabolism, and better insulin response.
  5. 5Implementation timeframe: Visible fat loss and metabolic improvements occur over 6 to 12 months of consistent use, with effects reversing if treatment stops.